Johnson Financial Group Inc. purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 21,390 shares of the company’s stock, valued at approximately $2,767,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Great Lakes Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $183,444,000. BOK Financial Private Wealth Inc. purchased a new position in shares of Merck KGaA in the second quarter worth $523,000. Avaii Wealth Management LLC bought a new stake in Merck KGaA during the 2nd quarter valued at $1,573,000. Compass Wealth Management LLC bought a new stake in Merck KGaA during the 2nd quarter valued at $834,000. Finally, Diversify Advisory Services LLC purchased a new stake in Merck KGaA during the 2nd quarter valued at $3,810,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of Merck KGaA stock opened at $167.38 on Thursday. The firm has a market cap of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company’s fifty day simple moving average is $162.50 and its two-hundred day simple moving average is $148.28.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
